Imeik Technology Development Co Ltd
SZSE:300896
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
134.05
282.72
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Imeik Technology Development Co Ltd
Imeik Technology Development Co Ltd
Other Current Assets
Imeik Technology Development Co Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Other Current Assets
¥33.5m
|
CAGR 3-Years
74%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Other Current Assets
¥1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Other Current Assets
¥35.8m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Other Current Assets
¥74.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Other Current Assets
¥27.6m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-14%
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Other Current Assets
¥93.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
30%
|
|
Imeik Technology Development Co Ltd
Glance View
Imeik Technology Development Co Ltd. is a pioneering player in the fast-growing field of biotechnology, primarily focusing on advanced skin care solutions. Founded in 2010, the company has rapidly positioned itself at the forefront of the beauty and personal care sectors in China. Leveraging cutting-edge research and development, Imeik specializes in hyaluronic acid products, which are widely recognized for their hydrating properties and overall skin improvement. The firm’s commitment to innovation and quality has not only allowed it to capture significant market share, but also to attract strategic partnerships with global brands. With a robust production capacity and a keen eye on market trends, Imeik aims to meet the increasing consumer demand for effective and scientifically-backed skincare solutions. In recent years, Imeik has witnessed impressive financial growth, driven by the expanding awareness of skincare among Chinese consumers and a surge in online retail. The company’s successful IPO on the Shenzhen Stock Exchange has positioned it for further expansion and development, putting capital towards research initiatives and marketing strategies that bolster brand recognition. As sustainability becomes more important to consumers, Imeik's focus on eco-friendly practices enhances its appeal, promising not only to captivate beauty enthusiasts but also to draw in investors looking for companies with a commitment to responsible practices. With their sights firmly set on international markets, Imeik Technology Development Co Ltd is poised for sustained growth, presenting an intriguing opportunity for investors eager to tap into the lucrative beauty and biotechnology sectors.
See Also
What is Imeik Technology Development Co Ltd's Other Current Assets?
Other Current Assets
33.5m
CNY
Based on the financial report for Dec 31, 2023, Imeik Technology Development Co Ltd's Other Current Assets amounts to 33.5m CNY.
What is Imeik Technology Development Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
55%
Over the last year, the Other Current Assets growth was 60%. The average annual Other Current Assets growth rates for Imeik Technology Development Co Ltd have been 74% over the past three years , 55% over the past five years .
You don't have any saved screeners yet
